Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gleevec in Non-Resectable Gastrointestinal Stromal Tumor
NCT00290485Phase 2Unknown
- Sponsor
- Hôpital Maisonneuve-Rosemont
- Start
- Aug 2005
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in gastrointestinal stromal tumor (GIST), sponsored by Hôpital Maisonneuve-Rosemont. Status: unknown.
02
Drugs
03
Conditions
gastrointestinal stromal tumor (GIST)
Beyond the preview
Go deeper on NCT00290485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00290485.